Aadi Bioscience, Inc. (AADI)
NASDAQ: AADI · IEX Real-Time Price · USD
1.430
-0.100 (-6.54%)
At close: Jul 19, 2024, 4:00 PM
1.440
+0.010 (0.70%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Aadi Bioscience Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Aadi Bioscience stock has a target of 5.00, which predicts an increase of 249.65% from the current stock price of 1.43.
Analyst Consensus: Buy
* Price targets were last updated on Dec 15, 2023.
Analyst Ratings
The average analyst rating for AADI stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 14, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $30 → $5 | Buy | Maintains | $30 → $5 | +249.65% | Dec 15, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 15, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $45 → $36 | Strong Buy | Maintains | $45 → $36 | +2,417.48% | Nov 13, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +3,046.85% | Aug 10, 2023 |
Financial Forecast
Revenue This Year
25.38M
from 24.35M
Increased by 4.21%
Revenue Next Year
27.56M
from 25.38M
Increased by 8.61%
EPS This Year
-2.59
from -2.44
EPS Next Year
-2.91
from -2.59
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 27.5M | 31.2M | 69.3M | 215.8M | 413.7M |
| Avg | 25.4M | 27.6M | 56.8M | 135.0M | 253.1M |
| Low | 22.6M | 24.9M | 35.7M | 48.5M | 64.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 12.8% | 22.9% | 151.4% | 279.7% | 206.5% |
| Avg | 4.2% | 8.6% | 106.2% | 137.5% | 87.5% |
| Low | -7.0% | -1.9% | 29.4% | -14.6% | -52.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.24 | -2.08 | -1.65 | -1.99 | 1.63 |
| Avg | -2.59 | -2.91 | -2.38 | -1.94 | 1.58 |
| Low | -2.79 | -3.28 | -3.09 | -1.86 | 1.52 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.